InsiderClue
Insiders · Profile

Davis Robert M

Chairman, CEO & President at Merck · Corporate Vice President at Baxter International. Filing since 14 Dec 2007. CIK 0001363076

MRK Merck & Co. Chairman, CEO & President · 8 trades BAX Baxter International Corporate Vice President · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MRK Merck & Co.
4 Feb 2026
Chairman, CEO & President
Sold at will
47,434
$5.60M
9.7%
MRK Merck & Co.
14 Feb 2024
Chairman, CEO & President
Sold at will
85,021
$10.66M
19.6%
MRK Merck & Co.
13 Feb 2024
Chairman, CEO & President
Sold at will
150,000
$18.88M
30.1%
MRK Merck & Co.
28 Apr 2023
Chairman, CEO & President
Sold at will
143,329
$16.47M
34.5%
MRK Merck & Co.
9 Nov 2022
CEO & President
Sold, plan not stated
167,613
$17.17M
40.4%
MRK Merck & Co.
5 Oct 2020
EVP, Global Svcs & CFO
Sold, plan not stated
251,273
$20.36M
59.5%
MRK Merck & Co.
25 Jun 2019
EVP, Global Svcs & CFO
Sold, plan not stated
216,718
$18.51M
61.2%
MRK Merck & Co.
25 Mar 2019
EVP, Global Svcs & CFO
Sold, plan not stated
192,572
$15.86M
58.3%
BAX Baxter International
17 May 2013
Corporate Vice President
Sold, plan not stated
130,800
$9.55M
52.1%
BAX Baxter International
25 Jul 2011
Corporate Vice President
Sold, plan not stated
101,000
$6.23M
63.6%
BAX Baxter International
14 Dec 2007
Corporate VP, CFO & Treasurer
Sold, plan not stated
20,000
$1.17M
50.3%
11 decisions on file.